Issue · Healthcare

Healthcare

Every healthcare bill, vote, and legislator stance in New York, automatically classified by Maddy, our AI policy reader.

Total bills
2,693
2025 Regular Session
Top supporter
Jessica Ramos
100% support rate
Top opponent
Dave DiPietro
7% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving healthcare in New York

Legislators moving healthcare in New York
Legislator Party Stance Support rate Decisive votes
Jessica Ramos
Jessica Ramos Senate · District 13
D
Strong +
100% 120
Jeremy Zellner
Jeremy Zellner Senate · District 61
D
Strong +
100% 65
Erik Bottcher
Erik Bottcher Senate · District 47
D
Strong +
100% 61
Keith Powers
Keith Powers House · District 74
D
Strong +
100% 18
Diana Moreno
Diana Moreno House · District 36
D
Strong +
100% 17
Dave DiPietro
Dave DiPietro House · District 147
R
Strong −
7% 30
Chris Friend
Chris Friend House · District 124
R
Strong −
8% 26
Mark Walczyk
Mark Walczyk Senate · District 49
R
Strong −
8% 147
Brian Manktelow
Brian Manktelow House · District 130
R
Strong −
10% 31
Chris Tague
Chris Tague House · District 102
R
Strong −
10% 31
Showing 1,371–1,380 of 2,693 bills

All healthcare bills

in committee · New York · Assembly May 29, 2026

A 6569: Enacts the consumer wheelchair repair bill of rights act

Enacts the "consumer wheelchair repair bill of rights act" requiring manufacturers to make available certain documentation, parts, embedded software, firmware, or tools necessary for repairing equipment; establishes a timely repair for wheelchair program; deems all wheelchair repairs needed within 5 years of initial prescription medically necessary.
signed · New York · Senate Nov 12, 2025

S 7807: Expands the definition of epinephrine devices to include epinephrine nasal sprays

Defines epinephrine device as a single-use device or nasal spray device used for the automatic injection or administration of a premeasured dose of epinephrine into the human body for the purpose of emergency treatment of a person appearing to experience anaphylactic symptoms.
in committee · New York · Assembly Jan 7, 2026

A 2349: Relates to imposing a nursing home purchase moratorium on those who own or have owned failing facilities

This bill prevents nursing home owners who have operated facilities with poor safety or quality inspection scores from purchasing new facilities for 24 months. It requires all applicants to disclose every nursing home they or their spouses own in the state, and the health department blocks purchases if any disclosed facility had recent violations. Owners must wait until the failing facility meets all standards for 24 consecutive months before buying new properties. The law applies to individuals, corporations, and other entities seeking to expand their nursing home operations.
Sub-Topics Long-Term Care
in committee · New York · Assembly Feb 10, 2026

A 5840: Relates to dispensing certain individuals with opioid reversal drugs upon discharge

Bill A 5840 requires hospitals and certain inpatient facilities to dispense at least two doses of opioid reversal drugs to individuals who appear to be at risk for a substance use disorder upon their discharge. This applies to discharges from emergency departments, general hospitals, and inpatient facilities licensed by the office of alcoholism and substance abuse services or the office of mental health. Additionally, the bill updates existing law to ensure hospitals inform individuals with or at risk for a substance use disorder about available treatment services upon treatment commencement, admission, or discharge. The goal is to provide at-risk individuals with immediate access to opioid reversal medication.
Sub-Topics Substance Abuse
in committee · New York · Assembly Jan 7, 2026

A 5356: Directs the office of mental health to conduct a study on the effects of abuse suffered while incarcerated on formerly incarcerated individuals

This bill requires the Office of Mental Health, working with the Department of Corrections and Community Supervision, to study how abuse experienced during incarceration affects formerly incarcerated individuals. The study must examine both short-term and long-term mental, behavioral, and physical health impacts, associated costs, and identify effective treatment approaches. Within one year of the bill's effective date, the Office must submit a report with findings and recommendations to the governor and legislative leaders. The bill directly affects formerly incarcerated people by mandating an analysis of abuse-related harms they face post-incarceration.
Sub-Topics Probation & Parole
in committee · New York · Assembly Jan 7, 2026

A 8183: Relates to requirements for certain mental health practitioners to be issued privilege to diagnose and develop assessment-based treatment plans

Provides alternate education and experience requirements for mental health counselors, marriage and family therapists, and psychoanalysts licensed prior to 06/24/2027, to be issued privilege to diagnose and develop assessment-based treatment plans; removes fees for application for such diagnostic privileges.
Sub-Topics Mental Health
in committee · New York · Assembly Jan 7, 2026

A 7472: Limits co-payments for physical and occupational therapy services

This bill limits out-of-pocket costs for physical and occupational therapy by capping co-payments at 20% of the total reimbursement paid to the provider. It directly affects insured individuals who use these services under group health, accident, or health insurance plans. The key provision requires all such policies to comply with the 20% co-payment limit, regardless of whether therapy is provided by a physician or a licensed therapist. This applies to services covered under physician referrals and replaces previous higher co-payment thresholds.
Sub-Topics Insurance
passed both · New York · Assembly Jun 3, 2026

A 9026: Requires the testing of baby food and infant formula for toxic heavy metals and the disclosure of such test results

This bill (A 9026, "Baby Food Safety and Transparency Act") requires baby food manufacturers sold in the state to test products for arsenic, cadmium, lead, and mercury at least monthly using accredited labs. Manufacturers must publicly disclose test results via QR codes on labels showing metal levels and linking to FDA health information. Products exceeding state-established safety limits (based on federal standards) cannot be sold. The law directly affects baby food manufacturers and aims to increase transparency for parents, supplementing but not replacing federal requirements.
in committee · New York · Assembly Jan 7, 2026

A 749: Provides for coordination between the department of health and the state long-term care ombudsperson regarding residential health care facilities

Provides for coordination between the department of health and the state long-term care ombudsperson regarding residential health care facilities, including such facilities' compliance with state and federal law, and histories of complaints.
Sub-Topics Long-Term Care
in committee · New York · Assembly Jan 7, 2026

A 6368: Enacts the "children and recovering mothers (CHARM) act"

Enacts the "children and recovering mothers (CHARM) act" to provide guidance, education and assistance to healthcare providers caring for expectant mothers with substance use disorder; provides for the screening of newborns for substance abuse exposure.
Sub-Topics Substance Abuse
Showing 1,371 to 1,380 of 2,693 bills